SCHEDULE OF STOCK WARRANTS (Details) |
12 Months Ended |
---|---|
Dec. 31, 2022
$ / shares
shares
| |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Warrants outstanding, outstanding number of options, shares | 1,587,965 |
Warrants exercisable, weighted average remaining life in years | 2 months 12 days |
Warrants exercisable, exercisable number of options, shares | 1,587,965 |
Warrant One [Member] | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Range of Exercise Price, Minimum | $ / shares | $ 4.25 |
Warrants outstanding, weighted average exercise price | $ / shares | $ 4.25 |
Warrants outstanding, outstanding number of options, shares | 1,587,965 |
Warrants exercisable, weighted average remaining life in years | 2 months 12 days |
Warrants exercisable, exercisable number of options, shares | 1,587,965 |
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average remaining contractual terms. No definition available.
|
X | ||||||||||
- Definition Number of shares warrants exercisable. No definition available.
|
X | ||||||||||
- Definition Share based compensation shares authorized under other than stock option plans exercise price range lower range limit. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|